Search

Your search keyword '"Viatris Inc. -- Forecasts and trends"' showing total 90 results
Start Over Descriptor "Viatris Inc. -- Forecasts and trends" Publication Year Range Last 10 years
90 results on '"Viatris Inc. -- Forecasts and trends"'

1. Epinephrine Autoinjector Market to Grow by USD 2.44 Billion (2024-2028), Driven by Rising Allergy Prevalence and AI-Powered Market Transformation - Technavio

Subjects
United States. Food and Drug Administration, Viatris Inc. -- Forecasts and trends, Allergic reaction -- Forecasts and trends, Allergy -- Forecasts and trends, Epinephrine -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: Report with the AI impact on market trends - The global epinephrine autoinjector market size is estimated to grow by USD [...]

Published
2024

2. Night Vision Disturbance Market Size was highest in the US among the 7MM, accounting for ~USD 1,754 Million which is further expected to rise at CAGR of 1.08% by 2034, estimated DelveInsight

Subjects
Viatris Inc. -- Forecasts and trends, Business -- Research, BCG vaccines -- Forecasts and trends -- Reports, BCG -- Forecasts and trends -- Reports, Epidemiology -- Forecasts and trends -- Reports, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-December 4, 2024-: Night Vision Disturbance Market Size was highest in the US among the 7MM, accounting for ~USD 1,754 Million which is further expected to rise at CAGR [...]

Published
2024

3. Viatris Inc (VTRS:NAS) Company Profile: Analytics, Extensive Financial Metrics, and Benchmark Against Averages and Top Companies Within its Industry

Subjects
Viatris Inc. -- Forecasts and trends, Plunkett Research, Ltd. -- Forecasts and trends, Financial analysis -- Forecasts and trends -- Reports, Marketing research firms -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries
Abstract

(GlobeNewswire) - The 'Viatris Inc (VTRS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry' company profile from Plunkett Research Ltd has been added to [...]

Published
2024

4. Bronchial Spasm Market Forecast 2032: FDA, EMA and PDMA Approvals, Epidemiology, Therapies, Companies by DelveInsight

Subjects
Viatris Inc. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Amphastar Pharmaceuticals -- Forecasts and trends, Business -- Research, Bronchial spasm -- Forecasts and trends, Brand equity -- Forecasts and trends, Drug approval -- Forecasts and trends, Epidemiology -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-June 10, 2024-: Bronchial Spasm Market Forecast 2032: FDA, EMA and PDMA Approvals, Epidemiology, Therapies, Companies by DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:10062024 Bronchial Spasm companies are GlaxoSmithKline, Merck Sharp [...]

Published
2024

5. Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale

Subjects
Viatris Inc. -- Forecasts and trends, Sustainability reporting -- Reports -- Forecasts and trends, Environmental sustainability -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-May 22, 2024-: Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale (C)1994-2024 M2 COMMUNICATIONS RDATE:21052024 * Company continues to supply high-quality medicines to approximately 1 billion patients [...]

Published
2024

6. Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale

Subjects
Viatris Inc. -- Forecasts and trends, World health -- Forecasts and trends -- Reports, Sustainability reporting -- Reports -- Forecasts and trends, Environmental sustainability -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

Company continues to supply high-quality medicines to approximately 1 billion patients annually Report chronicles Viatris' commitment to providing access to healthcare and building healthier communities Impactful story highlights include 'Empathy [...]

Published
2024

7. Active Pharmaceutical Ingredient Market Worth $238.3 billion

Subjects
Merck KGaA -- Forecasts and trends, Cambrex Corp. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Specialty chemicals industry -- Statistics -- Forecasts and trends, Industrial research -- Germany -- United States -- United Kingdom -- India, Pharmaceutical industry -- Statistics -- Forecasts and trends, Research and development, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

CHICAGO: MarketsandMarkets has issued the following news release: Active Pharmaceutical Ingredient Market in terms of revenue was estimated to be worth $163.5 billion in 2024 and is poised to reach [...]

Published
2024

8. Intrauterine Contraceptive Devices (IUD) Market to grow by USD 965.49 million at a CAGR of 3.98% from 2022 to 2027, AbbVie Inc. and Bayer AG are among the key companies

Subjects
Cooper Companies Inc. -- Forecasts and trends, Bayer AG -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Eyewear industry -- Forecasts and trends, Contraceptives -- Forecasts and trends, Contraceptives industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: The intrauterine contraceptive devices (IUD) market is estimated to grow by USD 965.49 million from 2023 to 2027 at a CAGR [...]

Published
2024

9. Osteoarthritis Therapeutics Market to grow by USD 3.96 billion from 2022-2027, North America to account for 32% of market growth - Technavio

Subjects
Bayer AG -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, Anika Therapeutics Inc. -- Forecasts and trends, GSK PLC -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Novartis AG -- Forecasts and trends, Horizon Therapeutics PLC -- Forecasts and trends, F. Hoffmann-La Roche Ltd. -- Forecasts and trends, Zimmer Biomet Holdings, Inc. -- Forecasts and trends, Abbott Laboratories (Abbott Park, Illinois) -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Antiarthritic agents -- Forecasts and trends, Osteoarthritis -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Jan. 16, 2024 /PRNewswire/ -- Thehttps://www.technavio.com/report/report/osteoarthritis-therapeutics-market-industry-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_wk03_2024_016_rep&utm_content=IRTNTR43212 size is expected to grow byUSD 3.96 billion from 2022 to 2027. In addition, the momentum of the market will progress at [...]

Published
2024

10. Allergy Immunotherapies Market to grow by USD 1.01 billion from 2022 to 2027; Europe to account for 53% of market growth - Technavio

Subjects
Merck KGaA -- Forecasts and trends, Shionogi & Company Ltd. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Torii Pharmaceutical Company Ltd. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Optum Inc. (White Plains, New York) -- Forecasts and trends, Computer software industry -- Forecasts and trends, Patient compliance -- Forecasts and trends, Immunotherapy -- Forecasts and trends, Ciclesonide -- Forecasts and trends, Allergic reaction -- Forecasts and trends, Allergy -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Jan. 15, 2024 /PRNewswire/ -- Thehttps://www.technavio.com/report/allergy-immunotherapies-market-industry-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_wk03_2024_019_rep&utm_content=IRTNTR41320 is expected to grow byUSD 1.01 billion from 2022 to 2027. In addition, the momentum of the market will progress at aCAGR [...]

Published
2024

11. Active Pharmaceutical Ingredients Market is to grow by USD 86.47 billion from 2023 to 2028, Asia to account for 52% of market growth - Technavio

Subjects
Cambrex Corp. -- Forecasts and trends, Indena S.p.A. -- Forecasts and trends, Koninklijke DSM N.V. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Apotex Inc. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Thermo Fisher Scientific Inc. -- Forecasts and trends, Aurobindo Pharma Ltd. -- Forecasts and trends, Cipla Ltd. -- Forecasts and trends, GSK PLC -- Forecasts and trends, Novartis AG -- Forecasts and trends, Sun Pharmaceutical Industries Ltd. -- Forecasts and trends, Scientific equipment and supplies industry -- Forecasts and trends, Specialty chemicals industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Jan. 5, 2024 /PRNewswire/ -- The https://www.technavio.com/report/active-pharmaceutical-ingredients-market-industry-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_week1_24_TI_019_rep&utm_content=IRTNTR40608 is expected to grow byUSD 86.47 billion from 2023 to 2028. In addition, the momentum of the market will progress at [...]

Published
2024

12. Insomnia Therapeutics Market to grow by USD 1 billion from 2022-2027 | North America to account for 60% of market growth - Technavio

Subjects
Astellas Pharma Inc. -- Forecasts and trends, Merck & Company Inc. -- Forecasts and trends, Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, Aurobindo Pharma Ltd. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Mallinckrodt PLC -- Forecasts and trends, Sun Pharmaceutical Industries Ltd. -- Forecasts and trends, Eisai Company Ltd. -- Forecasts and trends, Abbott Laboratories (Abbott Park, Illinois) -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Insomnia -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Nov. 27, 2023 /PRNewswire/ -- Thehttps://www.technavio.com/report/report/insomnia-therapeutics-market-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_wk48_2023_016_rep&utm_content=IRTNTR76428 size is expected to grow byUSD 1 billion from 2022 to 2027. In addition, the momentum of the market will progress at [...]

Published
2023

13. Biosimilars market size to increase by USD 42.22 billion | Market driven by the notable price advantage of biosimilars compared to biologics

Subjects
Biogen Inc. -- Forecasts and trends, Amgen Inc. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Gedeon Richter PLC -- Forecasts and trends, Novartis AG -- Forecasts and trends, Biocon Ltd. -- Forecasts and trends, F. Hoffmann-La Roche Ltd. -- Forecasts and trends, Fresenius SE & Company KGaA -- Forecasts and trends, Biological products industry -- Forecasts and trends, Medical care, Cost of -- Forecasts and trends, Medical test kit industry -- Forecasts and trends, Insulin glargine -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Medical equipment and supplies industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: The Biosimilars Market size is forecast to grow by USD 42.22 billion between 2022 and 2027, and the growth momentum will [...]

Published
2023

14. Biosimilars market size to increase by USD 42.22 billion | Market driven by the notable price advantage of biosimilars compared to biologics - Technavio

Subjects
Biogen Inc. -- Forecasts and trends, Amgen Inc. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Gedeon Richter PLC -- Forecasts and trends, Novartis AG -- Forecasts and trends, Biocon Ltd. -- Forecasts and trends, F. Hoffmann-La Roche Ltd. -- Forecasts and trends, Fresenius SE & Company KGaA -- Forecasts and trends, Biological products industry -- Forecasts and trends, Medical test kit industry -- Forecasts and trends, Insulin glargine -- Comparative analysis -- Forecasts and trends -- Reports, Biotechnology industry -- Forecasts and trends, Medical equipment and supplies industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Oct. 24, 2023 /PRNewswire/ -- The https://www.technavio.com/report/biosimilars-market-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=t47_report_wk43_2023_014_IP&utm_content=IRTNTR70710 size is forecast to grow byUSD 42.22 billion between 2022 and 2027, and the growth momentum will be accelerating at aCAGR [...]

Published
2023

15. Atopic Dermatitis Drugs Market to grow by USD 4.7 billion from 2022-2027 | North America to account for 36% of market growth- Technavio

Subjects
Astellas Pharma Inc. -- Forecasts and trends, Bayer AG -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Otsuka Holdings Company Ltd. -- Forecasts and trends, Incyte Corp. -- Forecasts and trends, Maruho Company Ltd. -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Atopic dermatitis -- Drug therapy, Drugs -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Oct. 17, 2023 /PRNewswire/ -- Thehttps://www.technavio.com/report/atopic-dermatitis-drugs-market-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_week42_018_rep&utm_content=IRTNTR75242 size is expected to grow byUSD 4.7 billion from 2022 to 2027. In addition, the momentum of the market will be progressing [...]

Published
2023

16. Topical Corticosteroids Market to grow by USD 1.09 billion from 2022-2027, Asia to account for 31% of market growth - Technavio

Subjects
Merck & Company Inc. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Astellas Pharma Inc. -- Forecasts and trends, Bayer AG -- Forecasts and trends, Cipla Ltd. -- Forecasts and trends, GSK PLC -- Forecasts and trends, Glenmark Pharmaceuticals Ltd. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Sun Pharmaceutical Industries Ltd. -- Forecasts and trends, Corticosteroids -- Reports -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Oct. 11, 2023 /PRNewswire/ -- Thehttps://www.technavio.com/report/topical-corticosteroids-market-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=t2023vrd_wk41_2023_016_rep&utm_content=IRTNTR75330 size is expected to grow byUSD 1.09 billion from 2022 to 2027. In addition, the momentum of the market will progress at [...]

Published
2023

17. Penicillin Market size is to grow by USD 2.45 billion from 2022 to 2027, North America to account for 31% of market growth - Technavio

Subjects
Merck KGaA -- Forecasts and trends, Hikma Pharmaceuticals PLC -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, F. Hoffmann-La Roche Ltd. -- Forecasts and trends, Abbott Laboratories (Abbott Park, Illinois) -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Astellas Pharma Inc. -- Forecasts and trends, GSK PLC -- Forecasts and trends, Glenmark Pharmaceuticals Ltd. -- Forecasts and trends, FUJIFILM Corp. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Sun Pharmaceutical Industries Ltd. -- Forecasts and trends, Penicillin G -- Forecasts and trends, Communicable diseases -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Photographic industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Oct. 2, 2023 /PRNewswire/ -- Thehttps://www.technavio.com/report/penicillin-market-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=T2023_VRD_wk40_2023_019_rep&utm_content=IRTNTR40093 is expected to grow byUSD 2.45 billion from 2022 to 2027. In addition, the momentum of the market will progress at aCAGR [...]

Published
2023

18. Breast Cancer Monoclonal Antibodies Market to grow by USD 15 billion from 2022 to 2027, North America to account for 42% of market growth - Technavio

Subjects
Merck KGaA -- Forecasts and trends, MacroGenics Inc. -- Forecasts and trends, Amgen Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Seagen Inc. -- Forecasts and trends, Daiichi Sankyo Company Ltd. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, F. Hoffmann-La Roche Ltd. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Gilead Sciences Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Eisai Company Ltd. -- Forecasts and trends, Biological products industry -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Breast cancer -- Forecasts and trends, Monoclonal antibodies -- Growth, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Sept. 18, 2023 /PRNewswire/ -- The https://www.technavio.com/report/breast-cancer-monoclonal-antibodies-market-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=T2023_VRD_wk38_2023_019_rep&utm_content=IRTNTR75974 is expected to grow byUSD 15 billion from 2022 to 2027. In addition, the momentum of the market will progress at [...]

Published
2023

19. Vertigo Drugs Market to grow by USD 551.42 million from 2022-2027, North America to account for 38% of market growth - Technavio

Subjects
GSK PLC -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Sun Pharmaceutical Industries Ltd. -- Forecasts and trends, F. Hoffmann-La Roche Ltd. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Emerging markets -- Reports -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Drugs -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Sept. 12, 2023 /PRNewswire/ -- Thehttps://www.technavio.com/report/report/vertigo-drugs-market-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_wk37&utm_content=IRTNTR75900 size is expected to grow byUSD 551.42 million from 2022 to 2027. In addition, the momentum of the market will progress at [...]

Published
2023

20. Female Sexual Dysfunction Treatment Market to grow by USD 7.76 billion from 2022-2027; North America to account for 61% of market growth - Technavio

Subjects
Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Palatin Technologies Inc. -- Forecasts and trends, Novo Nordisk A/S -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Biological products industry -- Forecasts and trends, Biological products -- Reports -- Forecasts and trends, Marketing -- Forecasts and trends -- Reports, Evidence-based medicine -- Reports -- Forecasts and trends, Sexual disorders -- Drug therapy, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Sept. 11, 2023 /PRNewswire/ -- Thehttps://www.technavio.com/report/female-sexual-dysfunction-treatment-market-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=t2023vrd_wk36_2023_016_rep&utm_content=IRTNTR70409 size is expected to grow byUSD 7.76 billion from 2022 to 2027. In addition, the momentum of the market will progress at [...]

Published
2023

21. Heparin Market size is set to grow by USD 3,009.44 million from 2022 to 2027|Growing prevalence of chronic conditions boosts the market- Technavio

Subjects
Baxter International Inc. (Deerfield, Illinois) -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Eisai Company Ltd. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Fresenius SE & Company KGaA -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following press release: The global heparin market size is estimated to grow by USD 3,009.44 million from 2022 to 2027, according to Technavio. The [...]

Published
2023

22. Heparin Market size is set to grow by USD 3,009.44 million from 2022 to 2027|Growing prevalence of chronic conditions boosts the market- Technavio

Subjects
Baxter International Inc. (Deerfield, Illinois) -- Forecasts and trends, Hikma Pharmaceuticals PLC -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Eisai Company Ltd. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Fresenius SE & Company KGaA -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Heparin -- Forecasts and trends -- Reports -- Market size, Medical test kit industry -- Forecasts and trends, International trade -- Forecasts and trends -- Reports, Medical equipment and supplies industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, International trade, Business, News, opinion and commentary
Abstract

NEW YORK, July 12, 2023 /PRNewswire/ -- The https://www.technavio.com/report/heparin-market-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=n1v2_wk28_2023_016_rep&utm_content=IRTNTR40831 size is estimated to grow byUSD 3,009.44 million from 2022 to 2027, according to Technavio. The market is estimated to grow [...]

Published
2023

23. Transdermal Medical Patch Market Size to Hit $10.79 Billion, Globally by 2028 - Exclusive Report by The Insight Partners

Subjects
Endo Pharmaceuticals Inc. -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Novartis AG -- Forecasts and trends, Hisamitsu Pharmaceutical Company Inc. -- Forecasts and trends, Insight Partners -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, UCB S.A. -- Forecasts and trends, Distribution channels -- Forecasts and trends -- Reports, Patient compliance -- Forecasts and trends -- Reports, Transdermal medication -- Forecasts and trends -- Reports, Venture capital companies -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Direct market channel, Retail/reseller channel, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Pune, India, June 09, 2023 (GLOBE NEWSWIRE) -- According to our latest study on 'https://www.globenewswire.com/Tracker?data=4y3cyxcxY3meQoXJy4V64kIqqI7SwOEEfyIrixTWNONQ1PJNa2iqz_ZKMrqyPIlBAeH5bdPKIvT7SLCdPPClg-RS_LZKijDDDB4nfG9YOO1j6ktAfMwGrWUpIGOGUpr8ucdk3-6z92xCu4e6qrAenaDtv2EbbSf4LhdAOrLIUCg5bvPyVqhyHMi7rZwlDA47 Size Report, Forecast to 2028 - COVID-19 Impact and Global Analysis - by Type, Application, [...]

Published
2023

24. Atopic dermatitis drugs market size to grow by USD 4,720.19 million from 2022 to 2027; High prevalence of atopic dermatitis boost the market - Technavio

Subjects
AbbVie Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Otsuka Holdings Company Ltd. -- Forecasts and trends, Incyte Corp. -- Forecasts and trends, Maruho Company Ltd. -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Medical care, Cost of -- Forecasts and trends, Atopic dermatitis -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Drugs -- Forecasts and trends -- Market size, Drug approval -- Forecasts and trends, Health products industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: The global atopic dermatitis drugs market size is estimated to grow by USD 4,720.19 million from 2022 to 2027, according to [...]

Published
2023

25. Atopic dermatitis drugs market size to grow by USD 4,720.19 million from 2022 to 2027; High prevalence of atopic dermatitis boost the market - Technavio

Subjects
AbbVie Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Otsuka Holdings Company Ltd. -- Forecasts and trends, Incyte Corp. -- Forecasts and trends, Maruho Company Ltd. -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Atopic dermatitis -- Drug therapy, International trade -- Forecasts and trends, Drugs -- Forecasts and trends, Drug approval -- Forecasts and trends, Market trend/market analysis, International trade, Business, News, opinion and commentary
Abstract

NEW YORK, May 31, 2023 /PRNewswire/ -- Thehttps://www.technavio.com/report/atopic-dermatitis-drugs-market-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=newn1v2_rep1_wk21_2023_007&utm_content=IRTNTR75242 size is estimated to grow byUSD 4,720.19 million from 2022 to 2027, according to Technavio. The market is estimated to grow at [...]

Published
2023

26. Post-Surgical Pain Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, and Forecast by DelveInsight | Novartis, MedinCell, Unither, Esteve, Formosa, Acadia, Teikoku

Subjects
Viatris Inc. -- Forecasts and trends, Business -- Research, BCG vaccines -- Forecasts and trends -- Reports, BCG -- Forecasts and trends -- Reports, Drug approval -- Reports -- Forecasts and trends, Epidemiology -- Forecasts and trends -- Reports, Pain -- Care and treatment, Pain, Postoperative -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-May 25, 2023-: Post-Surgical Pain Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, and Forecast by DelveInsight | Novartis, MedinCell, Unither, Esteve, Formosa, Acadia, Teikoku (C)1994-2023 M2 [...]

Published
2023

27. Intrauterine Contraceptive Devices (IUD) Market size to grow by USD 965.49 million between 2022 and 2027; AbbVie Inc., Bayer AG, DKT International among others, identified as key vendors - Technavio

Subjects
Cooper Companies Inc. -- Forecasts and trends, Bayer AG -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Eyewear industry -- Forecasts and trends, Contraceptives -- Forecasts and trends, Contraceptives industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary, DKT International
Abstract

NEW YORK, May 14, 2023 /PRNewswire/ -- The https://www.technavio.com/report/intrauterine-contraceptive-devices-market-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=latest+n3-seg_wk19_2023_005_&utm_content=IRTNTR44874 size is estimated to grow by USD 965.49 million during 2023-2027. However, the growth momentum will be progressing at a CAGR [...]

Published
2023

28. Small Molecule API Global Market Report 2023

Subjects
Cambrex Corp. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Sun Pharmaceutical Industries Ltd. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries
Abstract

(GlobeNewswire) - Reportlinker.com announces the release of the report 'Small Molecule API Global Market Report 2023' - https://www.reportlinker.com/p06451228/?utm_source=GNW , Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris [...]

Published
2023

29. Autoinjectors market size to grow by USD 134,014.58 million from 2022 to 2027, Driven by increasing prevalence of allergies and need for immediate care - Technavio

Subjects
Becton, Dickinson and Co. -- Forecasts and trends, Merck KGaA -- Forecasts and trends, Amgen Inc. -- Forecasts and trends, Bayer AG -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, GSK PLC -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, F. Hoffmann-La Roche Ltd. -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Medical test kit industry -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Allergic reaction -- Forecasts and trends, Medical equipment and supplies industry -- Forecasts and trends, Adalimumab -- Market size -- Forecasts and trends, Allergy -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: The autoinjectors market size is forecasted to increase by USD 134,014.58 million from 2022 to 2027, at a CAGR of 25.14%, [...]

Published
2023

30. Anaplastic Thyroid Cancer Drugs Market size to grow at a CAGR of 5.44% from 2021 to 2026, Driven by the high prevalence of thyroid cancer - Technavio

Subjects
Merck KGaA -- Forecasts and trends, Medtronic PLC -- Forecasts and trends, Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, Bayer AG -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Eisai Company Ltd. -- Forecasts and trends, Medical test kit industry -- Forecasts and trends, Antineoplastic agents -- Reports -- Market size -- Forecasts and trends, Medical equipment and supplies industry -- Forecasts and trends, Thyroid cancer -- Drug therapy, Pharmaceutical industry -- Forecasts and trends, Antimitotic agents -- Reports -- Market size -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: The anaplastic thyroid cancer drugs market size is forecasted to increase by USD 230.53 million from 2021 to 2026, at a [...]

Published
2023

31. Open-angle glaucoma therapeutics market size to grow by USD 2.58 billion from 2021 to 2026; AbbVie Inc. and Aerie Pharmaceuticals Inc, among others, emerge as key vendors - Technavio

Subjects
Santen Pharmaceutical Company Ltd. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Hikma Pharmaceuticals PLC -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, NicOx S.A. -- Forecasts and trends, Otsuka Pharmaceutical Company Ltd. -- Forecasts and trends, Patient compliance -- Forecasts and trends, Brinzolamide -- Market size -- Forecasts and trends, Drug approval -- Forecasts and trends, Open-angle glaucoma -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: The open-angle glaucoma therapeutics market size is forecasted to increase by USD 2.58 billion from 2021 to 2026, at a CAGR [...]

Published
2023

32. Ewing's Sarcoma Treatment Market size to grow by USD 302.5 million from 2021 to 2026, Driven by the growing awareness about and funding for Ewing's sarcoma - Technavio

Subjects
Merck & Company Inc. -- Forecasts and trends, Baxter International Inc. (Deerfield, Illinois) -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Sarcoma -- Drug therapy, Medical test kit industry -- Forecasts and trends, Ipilimumab -- Forecasts and trends -- Reports, Medical equipment and supplies industry -- Forecasts and trends, Vincristine -- Forecasts and trends -- Reports -- Market size, Chemotherapy -- Forecasts and trends -- Reports, Drug approval -- Reports -- Forecasts and trends, Cancer -- Chemotherapy, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: The Ewing's sarcoma treatment market size is forecast to increase by USD 302.5 million from 2021 to 2026, at a CAGR [...]

Published
2023

33. Alzheimers disease therapeutics market size to grow by USD 4,391.9 million between 2022 and 2027; AB Science SA, AbbVie Inc., among others, identified as key vendors - Technavio

Subjects
Biogen Inc. -- Forecasts and trends, Aurobindo Pharma Ltd. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Grifols S.A. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Eisai Company Ltd. -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Biological products industry -- Forecasts and trends, Alzheimer's disease -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: The Alzheimer's disease therapeutics market size is forecast to increase by USD 4,391.9 million from 2022 to 2027, at a CAGR [...]

Published
2023

34. Global Generic Pharmaceuticals Market Report 2023: Sector to Reach $682.9 Billion by 2030 at a CAGR of 8.3%

Subjects
Viatris Inc. -- Forecasts and trends, Hikma Pharmaceuticals PLC -- Forecasts and trends, Novartis AG -- Forecasts and trends, Sun Pharmaceutical Industries Ltd. -- Forecasts and trends, Sawai Pharmaceutical Company Ltd. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Distribution channels -- Forecasts and trends, Generic drugs -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Direct market channel, Retail/reseller channel, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following news release: The 'Generic Pharmaceuticals Market Size, Share & Trends Analysis Report By Type (Simple Generics, Specialty Generics, Biosimilars), By Route Of [...]

Published
2023

35. The Global Antifungal Medicines Market Will Surpass the USD 19 Billion Milestone by 2027 | DelveInsight

Subjects
Cadila Pharmaceuticals -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Gilead Sciences Inc. -- Forecasts and trends, Apotex Inc. -- Forecasts and trends, Sun Pharmaceutical Industries Ltd. -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Biological products industry -- Forecasts and trends, Generic drugs -- Forecasts and trends, Infection -- Forecasts and trends, Antifungal agents -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

New York, The global antifungal drugs market is expanding rapidly due to the increasing prevalence of various fungal infections such as fungal nail infections, ringworm, vaginal candidiasis, aspergillosis, candida infections [...]

Published
2023

36. Hospital Infection Therapeutics Market to grow at a CAGR of 4.98% from 2022 to 2027, antibiotics to be a major segment for the growth of the market - Technavio

Subjects
Merck & Company Inc. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, F. Hoffmann-La Roche Ltd. -- Forecasts and trends, Abbott Laboratories (Abbott Park, Illinois) -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Bayer AG -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, Gilead Sciences Inc. -- Forecasts and trends, GSK PLC -- Forecasts and trends, Novartis AG -- Forecasts and trends, Biological products industry -- Forecasts and trends, Urinary tract infections -- Drug therapy, Tetracycline -- Forecasts and trends -- Market size -- Health aspects, Medical research -- Forecasts and trends -- Health aspects, Medicine, Experimental -- Forecasts and trends -- Health aspects, Biotechnology industry -- Forecasts and trends, Antifungal agents -- Forecasts and trends -- Health aspects -- Market size, Gastrointestinal diseases -- Drug therapy, Tetracyclines -- Forecasts and trends -- Market size -- Health aspects, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: The global hospital infection therapeutics market size is estimated to grow by USD 3,106.6 million from 2022 to 2027, according to [...]

Published
2023

37. Liposomal products market size is set to grow by USD 3,183.63 million from 2022-2027; The rising incidence of fungal disorders will boost the market- Technavio

Subjects
Lubrizol Corp. -- Forecasts and trends, Spectrum Pharmaceuticals Inc. -- Forecasts and trends, Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, Baxter International Inc. (Deerfield, Illinois) -- Forecasts and trends, Gilead Sciences Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Bausch Health Companies Inc. -- Forecasts and trends, Merrimack Pharmaceuticals Inc. -- Forecasts and trends, Diseases -- United Kingdom -- Ireland -- North America -- Asia, Antifungal agents -- Forecasts and trends -- Market size, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, March 15, 2023 /PRNewswire/ -- The https://www.technavio.com/report/liposomal-products-market-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=newn1_report_wk11_2023_014&utm_content=IRTNTR71397 size is estimated to grow byUSD 3,183.63 million from 2022 to 2027, according to Technavio. The market is estimated to grow [...]

Published
2023

38. Osteoarthritis therapeutics market to grow at a CAGR of 8.97% from 2022 to 2027: Growth opportunities led by Abbott Laboratories and Alvogen Iceland ehf among others- Technavio

Subjects
Bayer AG -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, Anika Therapeutics Inc. -- Forecasts and trends, GSK PLC -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Novartis AG -- Forecasts and trends, Horizon Therapeutics PLC -- Forecasts and trends, F. Hoffmann-La Roche Ltd. -- Forecasts and trends, Zimmer Biomet Holdings, Inc. -- Forecasts and trends, Abbott Laboratories (Abbott Park, Illinois) -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Medical test kit industry -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Medical equipment and supplies industry -- Forecasts and trends, Osteoarthritis -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: The osteoarthritis therapeutics market size is estimated to increase by USD 3,962.95 million from 2022 to 2027, with a CAGR of [...]

Published
2023

39. Alzheimer's disease therapeutics market size to increase by USD 3.99 billion; North America to account for 37% of market growth - Technavio

Subjects
Aurobindo Pharma Ltd. -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Eisai Company Ltd. -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Alzheimer's disease -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Feb. 8, 2023 /PRNewswire/ -- Thehttps://www.technavio.com/report/alzheimers-disease-therapeutics-market-industry-size-analysis?utm_source=prnewswire&utm_medium=pressrelease+&utm_campaign=t47-rvo_wk06_2023_013_report&utm_content=IRTNTR40742 report has been published by Technavio. Market size is forecast to grow byUSD 3.99 billion between 2021 and 2026 at aCAGR of [...]

Published
2023

40. Interstitial cystitis (IC) drugs market size to increase by USD 369.58 million: Analysis of major players as well as the key contributor region - Technavio

Subjects
Astellas Pharma Inc. -- Forecasts and trends, Johnson & Johnson Inc. -- Forecasts and trends, Bayer AG -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Seikagaku Corp. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Sun Pharmaceutical Industries Ltd. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Drugs -- Forecasts and trends -- Market size -- Reports, Health products industry -- Forecasts and trends, Interstitial cystitis -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: North America will account for 35% of the global Interstitial cystitis (IC) drugs market growth. The increasing cases of interstitial cystitis [...]

Published
2023

41. Interstitial cystitis (IC) drugs market size to increase by USD 369.58 million: Analysis of major players as well as the key contributor region - Technavio

Subjects
Astellas Pharma Inc. -- Forecasts and trends, Johnson & Johnson Inc. -- Forecasts and trends, Bayer AG -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Seikagaku Corp. -- Forecasts and trends, Sun Pharmaceutical Industries Ltd. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Drugs -- Forecasts and trends -- Reports, Health products industry -- Forecasts and trends, Interstitial cystitis -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

North America will account for 35% of the global interstitial cystitis (IC) drugs market NEW YORK, Jan. 30, 2023 /PRNewswire/ -- North America will account for 35% of the global [...]

Published
2023

42. Global Motion Sickness Drugs Market 2022 to 2026: Featuring Aurobindo Pharma, Baxter International, Caleb Pharmaceuticals, Cipla and CVS Health Among Others

Subjects
CVS Health Corp. -- Forecasts and trends, Merck KGaA -- Forecasts and trends, Baxter International Inc. (Deerfield, Illinois) -- Forecasts and trends, Aurobindo Pharma Ltd. -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, Cipla Ltd. -- Forecasts and trends, GSK PLC -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, WellSpring Pharmaceutical Corp. -- Forecasts and trends, Prestige Consumer Healthcare Inc. -- Forecasts and trends, Medical test kit industry -- Forecasts and trends, Drugstores -- Forecasts and trends, Drugs -- Forecasts and trends -- Reports, Medical equipment and supplies industry -- Forecasts and trends, Motion sickness -- Reports -- Forecasts and trends, Health products industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-January 18, 2023-: Global Motion Sickness Drugs Market 2022 to 2026: Featuring Aurobindo Pharma, Baxter International, Caleb Pharmaceuticals, Cipla and CVS Health Among Others (C)1994-2023 M2 COMMUNICATIONS RDATE:18012023 The [...]

Published
2023

43. Dravet syndrome treatment market size to increase by USD 575.14 million; North America to contribute 38% of market growth - Technavio

Subjects
Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Supernus Pharmaceuticals Inc. -- Forecasts and trends, Sun Pharmaceutical Industries Ltd. -- Forecasts and trends, PTC Therapeutics Inc. -- Forecasts and trends, UCB S.A. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Jan. 17, 2023 /PRNewswire/ -- The https://www.technavio.com/report/dravet-syndrome-treatment-market-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=T47-RVO_wk03_2023_004_report&utm_content=IRTNTR45344 report has been published by Technavio. Market size is forecast to grow byUSD 575.14 million between 2022 and 2027 at aCAGR [...]

Published
2023

44. Generic drugs market size to increase by USD 176.25 billion; North America to contribute 37% of market growth - Technavio

Subjects
Merck & Company Inc. -- Forecasts and trends, Amgen Inc. -- Forecasts and trends, Baxter International Inc. (Deerfield, Illinois) -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Fresenius SE & Company KGaA -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Aurobindo Pharma Ltd. -- Forecasts and trends, Cipla Ltd. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Sun Pharmaceutical Industries Ltd. -- Forecasts and trends, Biocon Ltd. -- Forecasts and trends, Medical test kit industry -- Forecasts and trends, Generic drugs -- Reports -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Medical equipment and supplies industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Jan. 11, 2023 /PRNewswire/ -- The https://www.technavio.com/report/generic-drugs-market-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=newN1_wk02_2023_004_report&utm_content=IRTNTR44584 report has been published by Technavio. Market size is forecast to grow byUSD 176.25 billion between 2022 and 2027 at aCAGR [...]

Published
2023

45. Specialty Generics Global Market Report 2022: Ukraine-Russia War Impact

Subjects
Pfizer Inc. -- Forecasts and trends, Hikma Pharmaceuticals PLC -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Mylan N.V. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Bausch Health Companies Inc. -- Forecasts and trends, Apotex Inc. -- Forecasts and trends, Sun Pharmaceutical Industries Ltd. -- Forecasts and trends, Mallinckrodt PLC -- Forecasts and trends, STADA Arzneimittel AG -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Generic drugs -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Reportlinker has issued the following news release: Major players in the specialty generics market are Teva Pharmaceutical Industries Ltd, Endo International plc, Akorn Operating Company LLCA , Mylan [...]

Published
2022

46. Herpes treatment market to grow by 4.05% Y-O-Y in 2023; Increasing prevalence of herpes infection will drive growth - Technavio

Subjects
Merck & Company Inc. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Maruho Company Ltd. -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Fresenius SE & Company KGaA -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Cadila Healthcare Ltd. -- Forecasts and trends, Aurobindo Pharma Ltd. -- Forecasts and trends, Cipla Ltd. -- Forecasts and trends, Gilead Sciences Inc. -- Forecasts and trends, GSK PLC -- Forecasts and trends, Novartis AG -- Forecasts and trends, Sun Pharmaceutical Industries Ltd. -- Forecasts and trends, Herpes -- Drug therapy -- Health aspects, Herpesvirus diseases -- Drug therapy -- Health aspects, Pharmaceutical industry -- Forecasts and trends -- Health aspects, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: Herpes treatment market insights - Vendors: 15+, including AbbVie Inc., AiCuris Anti infective Cures AG, Aurobindo Pharma Ltd., Avet Pharmaceuticals Inc., [...]

Published
2022

47. Herpes treatment market to grow by 4.05% Y-O-Y in 2023; Increasing prevalence of herpes infection will drive growth - Technavio

Subjects
Merck & Company Inc. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Maruho Company Ltd. -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Fresenius SE & Company KGaA -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Cadila Healthcare Ltd. -- Forecasts and trends, Aurobindo Pharma Ltd. -- Forecasts and trends, Cipla Ltd. -- Forecasts and trends, Gilead Sciences Inc. -- Forecasts and trends, GSK PLC -- Forecasts and trends, Novartis AG -- Forecasts and trends, Sun Pharmaceutical Industries Ltd. -- Forecasts and trends, Biological products industry -- Forecasts and trends -- Health aspects, Medical test kit industry -- Forecasts and trends -- Health aspects, Medical equipment and supplies industry -- Forecasts and trends -- Health aspects, Herpes -- Drug therapy -- Health aspects, Herpesvirus diseases -- Drug therapy -- Health aspects, Pharmaceutical industry -- Forecasts and trends -- Health aspects, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Dec. 19, 2022 /PRNewswire/ -- Herpes treatment market insights - Vendors : 15+, including AbbVie Inc., AiCuris Anti infective Cures AG, Aurobindo Pharma Ltd., Avet Pharmaceuticals Inc., Cadila [...]

Published
2022

48. Epinephrine autoinjector market to grow at 8.07% Y-O-Y in 2023; Increasing prevalence of allergies will drive growth -Technavio

Subjects
Shionogi & Company Ltd. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Allergic reaction -- Statistics -- Forecasts and trends, Allergy -- Statistics -- Forecasts and trends, Epinephrine -- Statistics -- Forecasts and trends, Pharmaceutical industry -- Statistics -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Dec. 19, 2022 /PRNewswire/ -- Epinephrine autoinjector market insights - Vendors : 15+, including Adamis Pharmaceuticals Corp., ALK Abello AS, Amneal Pharmaceuticals Inc., BIOPROJET, Crossject, Halozyme Therapeutics Inc., [...]

Published
2022

49. Female sexual dysfunction treatment market to grow by 32.7% Y-O-Y from 2022 to 2023: Increased awareness about female sexual dysfunction will drive growth - Technavio

Subjects
Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Palatin Technologies Inc. -- Forecasts and trends, Novo Nordisk A/S -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Biological products industry -- Forecasts and trends, Sexual disorders -- Drug therapy, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: Female sexual dysfunction treatment market insights - Vendors: 15+, Including Assos Ilac, Cipla Ltd., Dare Bioscience Inc., Dr Reddy's Laboratories Ltd., [...]

Published
2022

50. Female sexual dysfunction treatment market to grow by 32.7% Y-O-Y from 2022 to 2023: Increased awareness about female sexual dysfunction will drive growth - Technavio

Subjects
Pfizer Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Palatin Technologies Inc. -- Forecasts and trends, Novo Nordisk A/S -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Sexual disorders -- Drug therapy, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Dec. 13, 2022 /PRNewswire/ --Female sexual dysfunction treatment market insights - Vendors: 15+, Including Assos Ilac, Cipla Ltd., Dare Bioscience Inc., Dr Reddy's Laboratories Ltd., Duchesnay Inc., Endo [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results